EFFICACY OF PAPILOCARE® VAGINAL GEL IN CLEARING HR HPV IN 6 MONTHS IN OVER 1,000 PATIENTS 1 7
PAPILOCARE® INTENSIVE REGIMEN** 3+3
PAPILOCARE® STANDARD REGIMEN* 1+5
NEW RESULTS
90
**
88%
80
***
70
***
72%
42%
60
*** 58%
67%
63%
57%
50
46%
40
30
20
n= 97 p<0.0001 vs control
n=124 p=0.0011 vs control
n=183 p<0.0001 vs baseline
n=86 p<0.0001 vs baseline
n=91 p=0.0767 vs control
n=192
10
0
Papilocare ®
Papilocare ®
Papilocare ®
Control
A CORUÑA HOSPITALET DE LLOBREGAT
ROMA
OBSERVATIONAL STUDY
CLINICAL TRIAL
CLINICAL TRIAL
2
NCT 04002154
NCT 04199260
NCT 04199078
*Standard regimen: 1 MONTH + 5 MONTHS 1 cannula per day for 1 MONTH + 1 cannula every other day for 5 MONTHS
**Intensive regimen: 3 MONTHS + 3 MONTHS 1 cannula per day for 3 MONTHS + 1 cannula every other day for 3 MONTHS
1. Serrano, Luis et al. “E cacy of a Coriolus versicolor-Based Vaginal Gel in Women With Human Papillomavirus-Dependent Cervical Lesions: The PALOMA Study.” Journal of lower genital tract disease vol. 25,2 (2021): 130-136. 2. Cortés Bordoy, Javier et al. “E ect of a Multi-Ingredient Coriolus-versicolor-Based Vaginal Gel in Women with HPV-Dependent Cervical Lesions: The Papilobs Real-Life Prospective Study.” Cancers vol. 15,15 3863. 29 Jul. 2023. 3. Criscuolo, Anna Angela et al. “Therapeutic E cacy of a Coriolus versicolor-Based Vaginal Gel in Women with Cervical Uterine High-Risk HPV Infection: A Retrospective Observational Study.” Advances in therapy vol. 38,2 (2021): 1202-1211. 4. Riera Blasco MR, Rupérez Pérez B, Lázaro Vicario I, Felgueroso A, Fontanet Pérez E, Aguayo Alba A. Coriolus versicolor and treatment of high-risk HPV. [Abstract-Oral Presentation]. J Low Genit Tract Dis. 2018 April; 22(2S):S9. 5. Gajino C. Use and results of a Coriolus versicolor-based vaginal gel in women HPV+ and/or abnormal pap smear attended in a regional spanish hospital. Preliminary analysis. [Abstract- 00097]. European Research Organization on Genital Infection and Neoplasia (EUROGIN). Lisbon, December 2-5, 2018. 6. Valasoulis G1, Michail G2, Chatzistamatiou K3, Pappa K4, Tsabazis N5, Athanasiou A6, et al. CLINICAL EVALUATION OF MULTI-INGREDIENT CORIOLUS-VERSICOLOR-BASED VAGINAL GEL APPLICATION IN GREEK WOMEN WITH HPV-INDUCED CERVICAL LESIONS– REAL WORLD DATA FROM PAPILOBS GR STUDY. [Poster Presentation] International Papillomavirus Conference (IPVC). Edinburgh 2024 7.Centeno C, Coll M, Fiol G, López B, Riera M, Valenzuela O, Sanmartín P. E cacy of a multi-ingredient Coriolus versicolor-based vaginal gel on High-risk HPV clearance: preliminary results from the PALOMA 2 clinical trial. [Oral Communication].10th Congress of the European Federation for Colposcopy Riga, September 18-21, 2024.
Made with FlippingBook - Online magazine maker